These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2343593)

  • 21. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
    Liaw YF; Huang MJ; Fan KD; Li KL; Wu SS; Chen TJ
    Ann Intern Med; 1993 Mar; 118(6):424-8. PubMed ID: 8439116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propylthiouracil-induced hepatic damage.
    Weiss M; Hassin D; Bank H
    Arch Intern Med; 1980 Sep; 140(9):1184-5. PubMed ID: 6893265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putting propylthiouracil in perspective.
    Cooper DS; Rivkees SA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1881-2. PubMed ID: 19401361
    [No Abstract]   [Full Text] [Related]  

  • 24. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
    Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
    J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.
    Pacini F; Sridama V; Refetoff S
    J Endocrinol Invest; 1982; 5(6):403-7. PubMed ID: 6221046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propylthiouracil-induced nonspecific interstitial pneumonia.
    Lee JY; Chung JH; Lee YJ; Park SS; Kim SY; Koo HK; Lee JH; Lee CT; Yoon HI
    Chest; 2011 Mar; 139(3):687-690. PubMed ID: 21362656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hepatotoxicity on beginning propylthiouracil therapy.
    Lock DR; Sthoeger ZM
    J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necrotizing vasculitis in a patient affected by autoimmune hyperthyroidism treated with propylthiouracil.
    Antonucci A; Bardazzi F; Iozzo I; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 2():S41-3. PubMed ID: 20482568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
    Gürlek A; Cobankara V; Bayraktar M
    Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
    Frenkel J; Téllez R; Reyes C; González G; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome.
    Gajic-Veljic M; Bonaci-Nikolic B; Lekic B; Skiljevic D; Ciric J; Zoric S; Stojimirovic B; Nikolic M
    Rheumatology (Oxford); 2015 Nov; 54(11):2061-70. PubMed ID: 26163691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S; Tzotzas T; Kaltsas T; Krassas GE
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propylthiouracil-associated hepatitis.
    Peter SA
    J Natl Med Assoc; 1991 Jan; 83(1):75-7. PubMed ID: 1994070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide.
    Wan P; Zhao X; Hunasehally RY; Shi R; Zheng J
    Int J Dermatol; 2012 Mar; 51(3):345-8. PubMed ID: 22348574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propylthiouracil-induced fatal hepatic necrosis.
    Limaye A; Ruffolo PR
    Am J Gastroenterol; 1987 Feb; 82(2):152-4. PubMed ID: 3812421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fulminant hepatic failure associated with propylthiouracil.
    Ruiz JK; Rossi GV; Vallejos HA; Brenet RW; Lopez IB; Escribano AA
    Ann Pharmacother; 2003 Feb; 37(2):224-8. PubMed ID: 12549953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propylthiouracil in the treatment of feline hyperthyroidism.
    Peterson ME
    J Am Vet Med Assoc; 1981 Sep; 179(5):485-7. PubMed ID: 7309615
    [No Abstract]   [Full Text] [Related]  

  • 40. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism.
    Imseis RE; Vanmiddlesworth L; Massie JD; Bush AJ; Vanmiddlesworth NR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):685-7. PubMed ID: 9467593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.